With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Adoptive Immunotherapy of Tr1 Cells to Improve Outcome of Allo-HSCT Treatment for Pediatric AML||Stanford University / Maria-Grazia Roncarolo, MD & Rosa Bachetta, MD||Reach Grants||2015||California|
|Novel Strategy for Reducing Radiation-Induced Morbidity and Treating Recurrent Medulloblasoma||Massachusetts General Hospital / Rakesh Jain, PhD||Reach Grants||2013||Massachusetts|
|Development of a Pharmacodynamic Marker of EWS-FLI1 Activity to Aid in the Clinical Translation of Targeted Therapies for Ewing sarcoma||Van Andel Research Institute / Patrick Grohar, MD, PhD||Reach Grants||2013||Michigan|
|Stroma Biology Identifies Heparin as a Differentiating Agent in Neuroblastoma||Duke University Medical Center / Gerard Blobe, MD, PhD||Reach Grants||2013||North Carolina|
|Therapeutic Reactivation of p53 to Overcome Apoptotic Resistance in Pediatric Leukemia||Dana-Farber Cancer Institute / Loren Walensky, MD, PhD & Kimberly Stegmaier, MD||Reach Grants||2015||Massachusetts|
|Targeting Novel Pediatric-Specific FLT3 Mutations||Fred Hutchinson Cancer Research Center / Soheil Meshinchi, MD,PhD||Reach Grants||2015||Washington|
|Development of a Novel Mer Tyrosine Kinase Inhibitor for Treatment of ALL||University of Colorado Denver / Doug Graham, MD, PhD||Reach Grants||2013||Colorado|
|Neural Stem Cell-Mediated Drug Delivery for Targeted Treatment of Medulloblastoma||Beckman Research Institute of City of Hope / Margarita Gutova, MD||Reach Grants||2013||California|
|Immunotherapy for Pediatric Atypical Teratoid/Rhabdoid Tumor||Baylor College of Medicine / William Decker, PhD||Reach Grants||2013||Texas|
|Therapeutic Targeting of PGBD5-induced DNA Repair Dependency in Pediatric Solid Tumors||Memorial Sloan-Kettering Cancer Center / Alex Kentsis, MD/PhD||Reach Grants||2017||New York|